AKTAN, F. Et Al. 2018. Effects of Probucol on K562 chronic myelogenous leukemia cell line. 16th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) .

AKTAN, F., KOÇ, A., BÜYÜKBİNGÖL, Z., & KARABAY, A. Z., (2018). Effects of Probucol on K562 chronic myelogenous leukemia cell line . 16th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)

AKTAN, FÜGEN Et Al. "Effects of Probucol on K562 chronic myelogenous leukemia cell line," 16th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC), 2018

AKTAN, FÜGEN Et Al. "Effects of Probucol on K562 chronic myelogenous leukemia cell line." 16th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) , 2018

AKTAN, F. Et Al. (2018) . "Effects of Probucol on K562 chronic myelogenous leukemia cell line." 16th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) .

@conferencepaper{conferencepaper, author={FÜGEN AKTAN Et Al. }, title={Effects of Probucol on K562 chronic myelogenous leukemia cell line}, congress name={16th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)}, city={}, country={}, year={2018}}